Thousands of breast cancer patients could avoid gruelling chemotherapy thanks to research carried out by a Welsh surgeon.
Simon Holt, a breast surgeon at Hywel Dda Local Health Board, led a study into a new test to help determine whether a breast cancer patient needs to have the treatment.
The National Institute for Health and Care Excellence (NICE) has approved the 'Oncotype DX' test, which is used in people with certain types of genes and who are assessed as being at intermediate risk of their cancer spreading.
The test measures the presence of biological characteristics in the tumour which may show how likely it is to grow and whether it is likely to spread. Combined with other clinical information, the test will help determine which patients are most suitable for chemotherapy.
More top news
Wales head coach Rob Howley admitted his side's performance 'simply wasn't good enough' against Scotland this afternoon.
It will be cloudy with outbreaks of rain at first, but most of the rain will clear by morning.
Despite leading at half time, Howley's men failed to score in the second half with Scotland racking up 20 points to seal the win.